| Record ID | marc_university_of_toronto/uoft.marc:2596721760:1303 |
| Source | University of Toronto |
| Download Link | /show-records/marc_university_of_toronto/uoft.marc:2596721760:1303?format=raw |
LEADER: 01303cam 22003010a 4500
008 841120s1983 ne a b 1 1 eng d
013 $a8309213
020 $a0444903798 (Elsevier Science Pub. Co.)
039 0 $a2$b3$c3$d3$e2
046 $aDNLM$cDNLM
060 $aW1 CU786M no.11 (P)
060 $a[QV 140 C641 1983]
090 8 $aRD 86 .V42C573 1983$bGERSTM$c1
245 00 $aClinical experiences with Norcuron (Org NC 45, vecuronium bromide) :$bsymposium, Geneva 21-22 April 1983 /$ceditors, S. Agoston ... [et al.].
260 0 $aAmsterdam ; Princeton :$bExcerpta Medica,$cc1983.
300 $axvi, 203 p. :$bill. --
440 0 $aCurrent clinical practice series.
500 $aCataloging in publication.
500 $aContains lectures given during a symposium held in Geneva, Switzerland.
504 $aIncludes bibliographical references andindex.
650 2 $aAnesthesiology$xcongresses
650 2 $aNeuromuscular Blocking Agents$xpharmacodynamics$xcongresses
650 2 $aPancuronium$xanalogs & derivatives$xcongresses
650 2 $aPancuronium$xpharmacodynamics$xcongresses
650 0 $aVecuronium bromide$xTesting$xCongresses.
700 10 $aAgoston, S.
948 $a07/15/1992$b08/05/2001
949 $aRD86 .V42 C573 1983$wLC$c1$i31761010539641$lSTACKS$mGERSTEIN$rY$sY$tBOOK$u26/8/1992